Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer

Publisher： Karger

E-ISSN： 1423-0291|79|1|24-33

ISSN： 1015-2008

Source： Pathobiology, Vol.79, Iss.1, 2012-01, pp. : 24-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer

By  

Pathobiology, Vol. 82, Iss. 5, 2015-0 ,pp. : 203-211

Karger

Access to resources Recommend Favorite

MCM2 and Ki-67 Expression in Human Lung Adenocarcinoma: Prognostic Implications

By  

Pathobiology, Vol. 71, Iss. 4, 2004-07 ,pp. : 193-200

Karger

Access to resources Recommend Favorite

Prognostic and Predictive Value of Cell Cycle Deregulation in Non-Small-Cell Lung Cancer

By  

Pathobiology, Vol. 79, Iss. 4, 2012-03 ,pp. : 175-194

Karger

Access to resources Recommend Favorite

PRO_10 – A New Tissue-Based Prognostic Multigene Marker in Patients with Early Estrogen Receptor-Positive Breast Cancer

By  

Pathobiology, Vol. 78, Iss. 3, 2011-05 ,pp. : 140-148

Karger

Access to resources Recommend Favorite

DNA Damage Response-Related Proteins in Gastric Cancer: ATM, Chk2 and p53 Expression and Their Prognostic Value

By  

Pathobiology, Vol. 81, Iss. 1, 2013-08 ,pp. : 25-35

Karger

Access to resources Recommend Favorite